NKTR Drug delivery Company Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : NKTR Drug delivery Company

NKTR 58.00

+3.6%

Nov 10 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: idos who wrote (346)	12/14/2010 12:54:58 PM
From: Arthur Radley	of 507

The CEO really threw us a curve ball, after being so forceful about doing a partnership deal. The data did appear to be good and improving from earlier data, however, short-term this decision to go it alone will put a damper on the stock. If the drug is a good as it appears(but sure is early data to put blockbuster by their name)then the decision to keep full control will be the wise option, but keeping their pipeline moving forward will require additional dilution.......ARRRGGGGH!

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next